Aligos Therapeutics Receives Upfront Payment Of $25M USD From The Exclusive License Deal Of Pevifoscorvir Sodium In Greater China For Chronic Hepatitis B Virus Infection

(MENAFN - GlobeNewsWire - Nasdaq) Breakthrough Therapy Designation granted for pevifoscorvir sodium in China SOUTH SAN FRANCISCO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. ...